149 related articles for article (PubMed ID: 1328283)
1. Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.
Sundqvist VA; Xu W; Wahren B
J Clin Microbiol; 1992 Oct; 30(10):2735-9. PubMed ID: 1328283
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.
Landini MP; Ripalti A; Sra K; Pouletty P
J Clin Microbiol; 1991 Sep; 29(9):1868-72. PubMed ID: 1723077
[TBL] [Abstract][Full Text] [Related]
3. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
4. Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides.
Novák J; Sova P; Krchnák V; Hamsíková E; Závadová H; Roubal J
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1409-13. PubMed ID: 1710650
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
[TBL] [Abstract][Full Text] [Related]
6. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Jahn G; Plachter B
J Clin Microbiol; 1995 Jul; 33(7):1927-30. PubMed ID: 7665674
[TBL] [Abstract][Full Text] [Related]
7. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
[TBL] [Abstract][Full Text] [Related]
8. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
10. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
Meyer T; Reischl U; Wolf H; Schüller C; Arndt R
Mol Cell Probes; 1994 Aug; 8(4):261-71. PubMed ID: 7870068
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins.
Van Zanten J; Lazzarotto T; Campisi B; Vornhagen R; Jahn G; Landini MP; The TH
New Microbiol; 1995 Apr; 18(2):223-8. PubMed ID: 7603351
[TBL] [Abstract][Full Text] [Related]
12. Prokaryotic expression of human cytomegalovirus pUS22 and its reactivity with human antibody.
Dal Monte P; Varani S; Lazzarotto T; Pignatelli S; Landini MP
Arch Virol; 1998; 143(12):2413-9. PubMed ID: 9930196
[TBL] [Abstract][Full Text] [Related]
13. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
14. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients.
Bein G; Bitsch A; Hoyer J; Steinhoff J; Fricke L; Machnik H; Dennin R; Kirchner H
Transpl Int; 1993; 6(4):185-90. PubMed ID: 8394089
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection.
van Zanten J; van der Giessen M; van Son WJ; The TH
J Med Virol; 1993 Jan; 39(1):80-7. PubMed ID: 8380844
[TBL] [Abstract][Full Text] [Related]
17. Characterization of host immunity to cytomegalovirus pp150 (UL32).
La Rosa C; Wang Z; Lacey SF; Markel SF; Sharma MC; Martinez J; Lalimarmo MM; Diamond DJ
Hum Immunol; 2005 Feb; 66(2):116-26. PubMed ID: 15694996
[TBL] [Abstract][Full Text] [Related]
18. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.
Greijer AE; van de Crommert JM; Stevens SJ; Middeldorp JM
J Clin Microbiol; 1999 Jan; 37(1):179-88. PubMed ID: 9854087
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
[TBL] [Abstract][Full Text] [Related]
20. Donated organs as a source of cytomegalovirus (CMV) in renal transplant patients.
Costa SC; Miranda SR; Alves G; Rossi CL; Figueiredo LT; Costa FF
Braz J Med Biol Res; 1994 Nov; 27(11):2573-8. PubMed ID: 7549979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
